Status:
NOT_YET_RECRUITING
The Effect of Omega-3 Fatty Acids in Patients With Rheumatoid Arthritis
Lead Sponsor:
Hopital Charles Nicolle
Conditions:
Rheumatoid Arthritis (RA)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this double-blinded randomized controlled trial (RCT) was to assess the effect of omega-3 intake versus placebo among patients with RA on the primary outcome of disease activity, and the se...
Detailed Description
Objective: The aim of this double-blinded randomized controlled trial (RCT) will be to assess the effect of omega-3 intake versus placebo among patients with RA on the primary outcome of disease acti...
Eligibility Criteria
Inclusion
- Adult patients ≥ 18 years
- Patients diagnosed with RA according to the Association of Rheumatology America (ACR) criteria, attending the Rheumatology Department of Charles Nicolle Hospital.
Exclusion
- Patients with allergy to fish and seafood
- Patients treated with anticoagulants and coagulation disorders
- Patients with severe hypertriglyceridemia associated with pancreatitis
- Patients with severe hepatic impairment
- Patients with severe renal impairment
- Current pregnancy or breastfeeding.
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT06881966
Start Date
September 1 2025
End Date
March 1 2026
Last Update
June 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charles Nicolle Hospital
Tunis, Bab Saadoun, Tunisia, 1006